BRCA Associated Tumors—Not Just Breast and Ovarian Cancer

نویسندگان

  • Priya Ranjit Bhosale
  • Tara Lynn Sagebiel
  • Elaine Ni Mhurchu
  • Sinead Helena McEvoy
  • Jeffrey William McCann
چکیده

Several attempts have been made in the past at imaging the fetus at 3T as part of the continuous search for increased image signal and better anatomic delineation of the developing fetus. Until now, imaging of the fetus at 3T has been disappointing, with numerous artifacts impeding image analysis. Improved technology now allows imaging of the fetus at greater magnetic strength, while still encountering some hurdles in the shape of imaging artifacts. In this course we present the preliminary experience of evaluating the developing fetus at 3T, discuss several artifacts encountered and techniques to decrease them, as well as safety concerns associated with scanning the fetus at higher magnetic strength. Fetal Cardiac MRI and Left Ventricular Function Assessment Using a New Gating Strategy Based on Doppler Ultrasound: Preliminary Results Fabian Kording (Presenter): Nothing to Disclose , Jin Yamamura MD : Nothing to Disclose , Chressen Catharina Remus MD : Nothing to Disclose , Manuela Tavares de Sousa : Nothing to Disclose , Friedrich Uberle : Nothing to Disclose , Gerhard B. Adam MD : Nothing to Disclose , Bjoern Schoennagel MD : Nothing to Disclose PURPOSE The commonly used method to evaluate the fetal heart is echocardiography (ECG). However, the detection of congenital heart diseases by ECG varies from 45% to 74% and an alternative imaging modality would be desirable. Fetal cardiac magnetic resonance imaging (MRI) has the potential to visualize anatomy and to assess functional parameters of the fetal heart but was up to now not feasible due to a missing gating strategy. The purpose of this study was to perform fetal cardiac MRI using a newly developed Doppler ultrasound sensor (DUS) for external fetal cardiac gating in a human fetus for the first time. METHOD AND MATERIALS One pregnant volunteer (gestation week 34) was examined at 1.5 T to evaluate the DUS gating method for fetal cine MRI. To obtain a gating signal from the fetal heart, an MRI compatible ultrasound transducer of a cardiotocogram was employed for cardiac triggering. DUS signals from the CTG were transferred to LabView with a data acquisition card. Trigger signals were processed based on a newly developed algorithm and transmitted to the physiologic unit of the MRI for cardiac gating. Retrospective cine imaging was then performed in four-chamber, long-axis and short-axis view. Left ventricular function parameters were assessed by cardiac cine MRI and compared to parameters obtained from consecutively performed standard ECG. RESULTS Cardiac gating signals from the fetus could be reliably detected. No artefacts and interferences were observed, resulting in very good image quality. The synchronous contraction of the ventricles was clearly visualized from the apex to the base with an average R-R interval of 464 ± 94 ms. End-systolic and end-diastolic volumes calculated from cine cardiac MRI and ECG were 0.58 ml / 0.62 ml and 3.17 ml / 3.22 ml, yielding stroke VSPD12-01

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The role of BRCA1 AND BRCA2 in hereditary breast cancer Review Article

BRCA1 and BRCA2 account for most cases of hereditary breast cancer in the United States and Europe. These are suppressor genes that are inherited in an autosomal dominant fashion. Several studies showed that the histologic and molecular phenotype of BRCA-associated tumors is different from that of nonhereditary tumors. There is a difference in steroid receptor status between BRCA1 and 2 tumors ...

متن کامل

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers

Predisposition to breast and ovarian cancer has been attributed to mutant BRCA1 alleles in 90% of hereditary combined tumors and in 45% of hereditary breast cases, whereas mutations in BRCA2 gene are thought to account for about 35% of inherited breast cancers. On the other hand, the presence of mutations in the sporadic forms of these tumors is an infrequent event. This suggests that tumors ar...

متن کامل

Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.

To investigate the role of BRCA1 and BRCA2 mutations in Korean patients with sporadic breast cancer, 793 breast cancer patients were analyzed by denaturing high performance liquid chromatography and direct sequencing. The 793 breast cancer patients enrolled in this study had no family history of affected first- or second-degree relatives with breast and/or ovarian cancer. Seventy-nine different...

متن کامل

Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.

PURPOSE/OBJECTIVES To investigate cancer surveillance behaviors of women at risk for hereditary breast and ovarian cancer (HBOC) who presented for clinical BRCA cancer susceptibility testing, specifically to describe cancer surveillance behaviors and reasons for not engaging in behaviors, compare surveillance behaviors with existing surveillance guidelines, and evaluate associations of cancer s...

متن کامل

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

DESCRIPTION Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. METHODS The USPSTF reviewed the evidence on risk assessment,genetic counseling, and genetic testing for potentially harmful BRCA mutations in asymptomatic women with a family history of breast or ovarian c...

متن کامل

BRCA in breast cancer: ESMO clinical recommendations.

Familial susceptibility to breast cancer accounts for 25% of all breast cancer cases. In familial breast cancer, mutations in the BRCA1, BRCA2, CHEK2, TP53 and PTEN genes account for 5–10% of breast and ovarian cancer cases overall. The prevalence of BRCA1 or BRCA2 mutations varies considerably between ethnic groups and geographical areas. Populationspecific mutations have been described in Ice...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014